| Boston Scientific Stent Gets EU Approval Boston Scientific received European clearance to sell its Taxus Element drug-coated stent, and it will be allowed to be marketed as a treatment for diabetic patients. online.wsj.com |
FDA to Review Weight-Loss Drug The FDA will review Vivus's experimental weight-loss drug on Thursday. It could be the first new obesity treatment approved in the U.S. since 1999. online.wsj.com |
National Dentex Completes Merger with GeoDigm, a Welsh, Carson, Anderson & Stowe Portfolio Company (Business Wire) NATICK, Mass.----National Dentex Corporation , one of the largest owner/operators of dental laboratories in North America, announced that earlier today its shareholders adopted and approved the Agreement and Plan of Merger among GDC Holdings, Inc., a Delaware corporation , Royal Acquisition Corp., a Delaware corporation and an indirect wholly owned subsidiary of Parent and a direct wholly owned subsidiary of GeoDigm Corporation, a Minnesota corporation , and National Dentex. us.rd.yahoo.com |
Egg Company Owner Apologizes As Lawmakers Examine Outbreak Iowa chicken farmer Austin DeCoster apologized to victims of the salmonella outbreak that led to the summer's nationwide egg recall and promised to take steps to prevent further contamination. online.wsj.com |
Pfizer Is Not Paying a Ransom for King EP Vantage submits:Considering King Pharmaceuticals' (KG) share price has not been anywhere close to $14.25 in the last three years, Pfizer’s (PFE) takeover offer will look pretty tempting to a lot of the company’s shareholders. The bid announced Tuesday morning values King at $3.6bn, 40% more than the pain specialist’s market value Monday. The move makes sense given Pfizer’s significant presence in CNS, led by blockbusters Lyrica and Celebrex, but less so when considering King’s far from spotless progress over the last 18 months in getting new products to market. A move typical for a company that cannot help itself when it comes to acquisitions, perhaps, but hardly one that will lessen the Lipitor patent cliff. Complete Story » seekingalpha.com |